- Combined effect of low dose atorvastatin, aspirin, clopidogrel and cessation of smoking for one year on totally occluded left anterior descending coronary artery in 39-year-old obese physician: a case report
Research Review · 2022
- Prevalence of Self-Reported Muscle Pain Among Statin Users From National Guard Hospital, Riyadh
Cureus · 2022
- Impact of three major risk factors on clinical outcomes in patients with nonvalvular atrial fibrillation receiving rivaroxaban: Sub‐analysis from the <scp>XAPASS</scp> study
Journal of Arrhythmia · 2022
- A Combined Pharmacometrics Analysis of Biomarker Distribution Under Treatment With Standard- or Low-Dose Rivaroxaban in Real-World Chinese Patients With Nonvalvular Atrial Fibrillation
Frontiers in Pharmacology · 2022
- Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study
Frontiers in Cardiovascular Medicine · 2022
- N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells
Arteriosclerosis Thrombosis and Vascular Biology · 2022
- A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
Frontiers in Cardiovascular Medicine · 2022
- Observed Apixaban Anti-Xa Levels in Obese Patients
Annals of Pharmacotherapy · 2022
- Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital
University Heart Journal · 2022
- Safety Issues Associated With the Clinical Application of PCSK9 Inhibitors: Current Findings
Cardiology in Review · 2022
- Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins
Journal of Clinical Pharmacy and Therapeutics · 2022
- Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry
Journal of Cardiovascular Pharmacology · 2022
- Prevention of thromboembolism in orthopedic surgery: Application of rivaroxaban in arthroplastic procedures
Galenika Medical Journal · 2022
- Direct oral anticoagulants and peripheral arterial disease
Galenika Medical Journal · 2022
- New oral anticoagulants in nonvalvular atrial fibrillation
Galenika Medical Journal · 2022
- Evaluation of the Effects of Folic Acid Combined with Atorvastatin on the Poststroke Cognitive Impairment by Low‐Rank Matrix Denoising Algorithm‐Based MRI Imaging
Contrast Media & Molecular Imaging · 2022
- Dietary astaxanthin-rich extract ameliorates atherosclerosis/retinopathy and restructures gut microbiome in apolipoprotein E-deficient mice fed on a high-fat diet
Food & Function · 2022
- Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease
Arteriosclerosis Thrombosis and Vascular Biology · 2021
- EFFECT OF RIVAROXABAN ON THE DYNAMIC OF MYOCARDIAL ISCHEMIA INDICATORS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER MYOCARDIAL INFARCTION
Likarska sprava · 2021
- The ‘real world’ is relative—biased
European Journal of Preventive Cardiology · 2021
- Effects of Low-Dose Atorvastatin on the Peripheral Blood Mononuclear Cell Secretion of Angiogenic Factors in Type 2 Diabetes
Biomolecules · 2021
- Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
Neurología (English Edition) · 2021
- Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
BMC Cardiovascular Disorders · 2021
- Exploring Pleiotropic Effects of Lipid Modifiers and Targets on Measures of the Coagulation System with Genetics
Thrombosis and Haemostasis · 2021
- Effect of atorvastatin on serum periostin and blood eosinophils in asthma – a placebo-controlled randomized clinical trial
Journal of International Medical Research · 2021
- The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study
Journal of Psychopharmacology · 2021
- Beneficial Effects of Fixed-Dose Combination of Amlodipine and Atorvastatin in Patients with Concomitant Hypertension and Hypercholesterolemia: A Multi-Institutional Cohort Study
2021
- Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis
Nutrition Metabolism and Cardiovascular Diseases · 2021
- How to handle the delayed or the missed dose of edoxaban in patients with non-valvular atrial fibrillation: model-informed remedial strategy
2021
- Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro
British Journal of Haematology · 2021
- Validated Spectrophotometric Methods for Simultaneous Determination of Atorvastatin Calcium and Olmesartan Medoxomil in Their Pharmaceutical Formulation
Journal of AOAC International · 2021
- The Effect of Rivaroxaban on CYP4F2 and Transcription Factors’ Activity in HUVECs
Applied Sciences · 2021
- Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice
Journal of Clinical Medicine · 2021
- Effect of pharmacological interventions on lipid profiles and C‐reactive protein in polycystic ovary syndrome: A systematic review and meta‐analysis
Clinical Endocrinology · 2021
- Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines
Rational Pharmacotherapy in Cardiology · 2021
- Conservative management of massive rivaroxaban overdose: A case report and literature review
Clinical Case Reports · 2021
- Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
Evidence-based Complementary and Alternative Medicine · 2021
- Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
Current Atherosclerosis Reports · 2021
- Evolocumab in patients with homozygous familial hypercholesterolemia in India
Journal of clinical lipidology · 2021
- Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
American Journal of Cardiovascular Drugs · 2021
- Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Frontiers in Cardiovascular Medicine · 2021
- Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients
Viruses · 2021
- Emerging agents for the treatment and prevention of stroke: progress in clinical trials
Expert Opinion on Investigational Drugs · 2021
- Belgian data of ODYSSEY APPRISE: stringent LDL‐c targets are in reach when using all available tools
International Journal of Clinical Practice · 2021
- How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators
Panminerva Medica · 2021
- Atorvastatin rescues pulmonary artery hypertension by inhibiting the AKT/ERK-dependent PDGF-BB/HIF-1α axis
Panminerva Medica · 2021
- Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy
Russian Journal of Cardiology · 2021
- Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation‐associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report
Journal of Diabetes Investigation · 2021
- Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Real-World Experience from a Single Spanish Regional Hospital
2021
- Safety and Efficacy of Non-Vitamin K Antagonists in Atrial Fibrillation in the real world: A pooled-analysis and comparison of XANTUS and ETNA-AF-EU studies
2021